GCC Invasive Neurostimulation Devices Market Eyes US$ 82.2 Million Valuation by 2033
The GCC invasive neurostimulation devices industry is benefiting from increasing healthcare expenditure, rising awareness of advanced neurological treatments, and continuous innovation in implantable neuromodulation technologies. Growing demand for neurostimulation devices for chronic pain management and neurological care is further supporting market expansion across the GCC region.
According...
